Jonathan A. kelber, Ph.D. - Publications

Affiliations: 
Biology California State University, Northridge, Los Angeles, CA, United States 
Area:
Cancer and Regenerative biology, receptor and non-receptor kinases
Website:
http://developmentaloncogenelab.gutensite.net/

32 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Conner C, Lager TW, Guldner IH, Wu MZ, Hishida Y, Hishida T, Ruiz S, Yamasaki AE, Gilson RC, Belmonte JCI, Gray PC, Kelber JA, Zhang S, Panopoulos AD. Cell surface GRP78 promotes stemness in normal and neoplastic cells. Scientific Reports. 10: 3474. PMID 32103065 DOI: 10.1038/s41598-020-60269-y  1
2019 Güth R, Adamian Y, Geller C, Molnar J, Maddela J, Kutscher L, Bhakta K, Meade K, Kim SL, Agajanian M, Kelber JA. DHPS-dependent hypusination of eIF5A1/2 is necessary for TGFβ/fibronectin-induced breast cancer metastasis and associates with prognostically unfavorable genomic alterations in TP53. Biochemical and Biophysical Research Communications. PMID 31558321 DOI: 10.1016/j.bbrc.2019.09.075  1
2019 Meade KJ, Sanchez F, Aguayo A, Nadales N, Hamalian SG, Uhlendorf TL, Banner LR, Kelber JA. Secretomes from metastatic breast cancer cells, enriched for a prognostically unfavorable LCN2 axis, induce anti-inflammatory MSC actions and a tumor-supportive premetastatic lung. Oncotarget. 10: 3027-3039. PMID 31105883 DOI: 10.18632/oncotarget.26903  0.6
2018 Hoover M, Runa F, Booker E, Diedrich JK, Duell E, Williams B, Arellano-Garcia C, Uhlendorf T, La Kim S, Fischer W, Moresco J, Gray PC, Kelber JA. Identification of myosin II as a cripto binding protein and regulator of cripto function in stem cells and tissue regeneration. Biochemical and Biophysical Research Communications. PMID 30579599 DOI: 10.1016/j.bbrc.2018.12.059  1
2017 Runa F, Hamalian S, Meade K, Shisgal P, Gray PC, Kelber JA. Tumor microenvironment heterogeneity: challenges and opportunities. Current Molecular Biology Reports. 3: 218-229. PMID 29430386 DOI: 10.1007/s40610-017-0073-7  1
2017 Gharibi A, La Kim S, Molnar J, Brambilla D, Adamian Y, Hoover M, Hong J, Lin J, Wolfenden L, Kelber JA. ITGA1 is a pre-malignant biomarker that promotes therapy resistance and metastatic potential in pancreatic cancer. Scientific Reports. 7: 10060. PMID 28855593 DOI: 10.1038/s41598-017-09946-z  1
2017 Strnadel J, Choi S, Fujimura K, Wang H, Zhang W, Wyse M, Wright T, Gross E, Peinado C, Park HW, Bui J, Kelber J, Bouvet M, Guan KL, Klemke RL. eIF5A-PEAK1 Signaling Regulates YAP1/TAZ Protein Expression and Pancreatic Cancer Cell Growth. Cancer Research. PMID 28381547 DOI: 10.1158/0008-5472.CAN-16-2594  1
2016 Runa F, Adamian Y, Kelber JA. Ascending the PEAK1 toward targeting TGFβ during cancer progression: Recent advances and future perspectives. Cancer Cell & Microenvironment. 3. PMID 29392163 DOI: 10.14800/ccm.1162  1
2016 Hoover M, Adamian Y, Brown M, Maawy A, Chang A, Lee J, Gharibi A, Katz MH, Fleming J, Hoffman RM, Bouvet M, Doebler R, Kelber JA. A novel method for RNA extraction from FFPE samples reveals significant differences in biomarker expression between orthotopic and subcutaneous pancreatic cancer patient-derived xenografts. Oncotarget. PMID 27602776 DOI: 10.18632/oncotarget.11809  1
2016 Gharibi A, Adamian Y, Kelber JA. Cellular and molecular aspects of pancreatic cancer. Acta Histochemica. 118: 305-16. PMID 26868366 DOI: 10.1016/j.acthis.2016.01.009  1
2015 Agajanian M, Runa F, Kelber JA. Identification of a PEAK1/ZEB1 signaling axis during TGFβ/fibronectin-induced EMT in breast cancer. Biochemical and Biophysical Research Communications. 465: 606-12. PMID 26297948 DOI: 10.1016/j.bbrc.2015.08.071  1
2015 Agajanian M, Campeau A, Hoover M, Hou A, Brambilla D, Kim SL, Klemke RL, Kelber JA. PEAK1 Acts as a Molecular Switch to Regulate Context-Dependent TGFβ Responses in Breast Cancer. Plos One. 10: e0135748. PMID 26267863 DOI: 10.1371/journal.pone.0135748  1
2015 Agajanian M, Runa F, Kelber JA. Identification of a PEAK1/ZEB1 signaling axis during TGFβ/fibronectin-induced EMT in breast cancer Biochemical and Biophysical Research Communications. DOI: 10.1016/j.bbrc.2015.08.071  1
2015 Gharibi A, Adamian Y, Kelber JA. Cellular and molecular aspects of pancreatic cancer Acta Histochemica. DOI: 10.1016/j.acthis.2016.01.009  1
2014 Fujimura K, Wright T, Strnadel J, Kaushal S, Metildi C, Lowy AM, Bouvet M, Kelber JA, Klemke RL. A hypusine-eIF5A-PEAK1 switch regulates the pathogenesis of pancreatic cancer. Cancer Research. 74: 6671-81. PMID 25261239 DOI: 10.1158/0008-5472.CAN-14-1031  1
2014 Spike BT, Kelber JA, Booker E, Kalathur M, Rodewald R, Lipianskaya J, La J, He M, Wright T, Klemke R, Wahl GM, Gray PC. CRIPTO/GRP78 signaling maintains fetal and adult mammary stem cells ex vivo. Stem Cell Reports. 2: 427-39. PMID 24749068 DOI: 10.1016/j.stemcr.2014.02.010  1
2014 Choi S, Kelber J, Jiang X, Strnadel J, Fujimura K, Pasillas M, Coppinger J, Klemke R. Procedures for the biochemical enrichment and proteomic analysis of the cytoskeletome. Analytical Biochemistry. 446: 102-7. PMID 24161902 DOI: 10.1016/j.ab.2013.10.025  1
2013 Klemke RL, Jiang X, Choi S, Kelber JA. Proteomic and biochemical methods to study the cytoskeletome. Methods in Molecular Biology (Clifton, N.J.). 1046: 203-18. PMID 23868590 DOI: 10.1007/978-1-62703-538-5_12  1
2013 Stoletov K, Strnadel J, Zardouzian E, Momiyama M, Park FD, Kelber JA, Pizzo DP, Hoffman R, VandenBerg SR, Klemke RL. Role of connexins in metastatic breast cancer and melanoma brain colonization. Journal of Cell Science. 126: 904-13. PMID 23321642 DOI: 10.1242/jcs.112748  1
2012 Soman P, Kelber JA, Lee JW, Wright TN, Vecchio KS, Klemke RL, Chen S. Cancer cell migration within 3D layer-by-layer microfabricated photocrosslinked PEG scaffolds with tunable stiffness. Biomaterials. 33: 7064-70. PMID 22809641 DOI: 10.1016/j.biomaterials.2012.06.012  1
2012 Kelber JA, Reno T, Kaushal S, Metildi C, Wright T, Stoletov K, Weems JM, Park FD, Mose E, Wang Y, Hoffman RM, Lowy AM, Bouvet M, Klemke RL. KRas induces a Src/PEAK1/ErbB2 kinase amplification loop that drives metastatic growth and therapy resistance in pancreatic cancer. Cancer Research. 72: 2554-64. PMID 22589274 DOI: 10.1158/0008-5472.CAN-11-3552  1
2011 Allendorph GP, Read JD, Kawakami Y, Kelber JA, Isaacs MJ, Choe S. Designer TGFβ superfamily ligands with diversified functionality. Plos One. 6: e26402. PMID 22073163 DOI: 10.1371/journal.pone.0026402  1
2011 Kelber JA, Klemke RL. The Actin Cytoskeleton Cellular Domains. 197-212. DOI: 10.1002/9781118015759.ch12  1
2010 Kelber JA, Klemke RL. PEAK1, a novel kinase target in the fight against cancer. Oncotarget. 1: 219-23. PMID 21301050  1
2010 Wang Y, Kelber JA, Tran Cao HS, Cantin GT, Lin R, Wang W, Kaushal S, Bristow JM, Edgington TS, Hoffman RM, Bouvet M, Yates JR, Klemke RL. Pseudopodium-enriched atypical kinase 1 regulates the cytoskeleton and cancer progression [corrected]. Proceedings of the National Academy of Sciences of the United States of America. 107: 10920-5. PMID 20534451 DOI: 10.1073/pnas.0914776107  1
2010 Stoletov K, Kato H, Zardouzian E, Kelber J, Yang J, Shattil S, Klemke R. Visualizing extravasation dynamics of metastatic tumor cells. Journal of Cell Science. 123: 2332-41. PMID 20530574 DOI: 10.1242/jcs.069443  1
2010 Wang Y, Kelber JA, Tran Cao HS, Cantin GT, Lin R, Wang W, Kaushal S, Bristow JM, Edgington TS, Hoffman RM, Bouvet M, Yates JR, Klemke RL. Pseudopodium-enriched atypical kinase 1 regulates the cytoskeleton and cancer progession (Proceedings of the National Academy of Sciences of the United States of America (2010) 107, 24 (10920-10925) DOI: 10.1073/pnas.0914776107) Proceedings of the National Academy of Sciences of the United States of America. 107: 13556. DOI: 10.1073/pnas.1008849107  1
2009 Kelber JA, Panopoulos AD, Shani G, Booker EC, Belmonte JC, Vale WW, Gray PC. Blockade of Cripto binding to cell surface GRP78 inhibits oncogenic Cripto signaling via MAPK/PI3K and Smad2/3 pathways. Oncogene. 28: 2324-36. PMID 19421146 DOI: 10.1038/onc.2009.97  1
2008 Kelber JA, Shani G, Booker EC, Vale WW, Gray PC. Cripto is a noncompetitive activin antagonist that forms analogous signaling complexes with activin and nodal. The Journal of Biological Chemistry. 283: 4490-500. PMID 18089557 DOI: 10.1074/jbc.M704960200  1
2008 Shani G, Fischer WH, Justice NJ, Kelber JA, Vale W, Gray PC. GRP78 and Cripto form a complex at the cell surface and collaborate to inhibit transforming growth factor beta signaling and enhance cell growth. Molecular and Cellular Biology. 28: 666-77. PMID 17991893 DOI: 10.1128/MCB.01716-07  1
2008 Gray PC, Shani G, Aung K, Kelber J, Vale W. Cripto binds transforming growth factor β (TGF-β) and inhibits TGF-β signaling (Molecular and Cellular Biology (2006) 26, 24, (9268-9278)) Molecular and Cellular Biology. 28: 7260. DOI: 10.1128/MCB.01609-08  1
2006 Gray PC, Shani G, Aung K, Kelber J, Vale W. Cripto binds transforming growth factor beta (TGF-beta) and inhibits TGF-beta signaling. Molecular and Cellular Biology. 26: 9268-78. PMID 17030617 DOI: 10.1128/MCB.01168-06  1
Show low-probability matches.